发明申请
US20100261716A1 INDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS
有权
吲哚 - 羧酰胺化合物作为5-HT4受体激动剂
- 专利标题： INDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS
- 专利标题（中）： 吲哚 - 羧酰胺化合物作为5-HT4受体激动剂
-
申请号： US12689763申请日： 2010-01-19
-
公开(公告)号： US20100261716A1公开(公告)日： 2010-10-14
- 发明人: Daniel Marquess , Seok-Ki Choi , Paul R. Fatheree , Roland Gendron , Adam A. Goldblum , Daniel D. Long , S. Derek Turner , Jyanwei Liu
- 申请人： Daniel Marquess , Seok-Ki Choi , Paul R. Fatheree , Roland Gendron , Adam A. Goldblum , Daniel D. Long , S. Derek Turner , Jyanwei Liu
- 申请人地址： US CA South San Francisco
- 专利权人： THERAVANCE, INC.
- 当前专利权人： THERAVANCE, INC.
- 当前专利权人地址： US CA South San Francisco
- 主分类号： A61K31/541
- IPC分类号： A61K31/541 ; A61P1/00 ; A61K31/496 ; A61K31/46
摘要：
The invention provides novel indazole-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
公开/授权文献
- US08044045B2 Indazole-carboxamide compounds as 5-HT4 receptor agonists 公开/授权日：2011-10-25
信息查询
